Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention

Area of Science:

• Rheumatology and Dermatology
• Inflammatory Arthritis Research
• Genetics and Environmental Factors in Disease

Background:

• Psoriatic arthritis (PsA) affects approximately 30% of individuals with skin psoriasis, involving synovial and entheseal tissues.
• Skin psoriasis typically precedes the onset of PsA by several years, presenting a valuable model for studying disease development.
• The early presence of psoriasis offers a unique window for detecting PsA and enabling earlier, potentially more effective interventions.

Discussion:

• Despite psoriasis presence, delayed diagnosis of PsA is common, leading to adverse long-term outcomes and significant joint damage.
• Screening questionnaires in primary care and dermatology settings reveal a high prevalence of undiagnosed PsA.
• Identifying risk factors like obesity, smoking, genetic profiles, and utilizing advanced imaging can facilitate targeted PsA screening.

Key Insights:

• Skin psoriasis is a critical indicator for potential psoriatic arthritis development.
• Early diagnosis of PsA in psoriasis patients is essential to mitigate long-term joint damage and disability.
• Integrated screening approaches combining clinical factors and biomarkers can improve early PsA detection.

Outlook:

• Future strategies aim to detect PsA at much earlier stages, before irreversible joint damage occurs.
• Targeted screening protocols incorporating genetic, biomarker, and imaging data will enhance early detection rates.
• Proactive identification and intervention in psoriasis patients can significantly reduce the burden of psoriatic arthritis.